SCHEMBL3781671

SCHEMBL3781671

CCCOc1ccc(Cl)cc1OCCC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
PKM P14618 1/20 0.54
CSNK2A1 P68400 2/20 0.51
HTR2C P28335 2/20 0.51
HTR2B P41595 2/20 0.51
KDM4E B2RXH2 2/20 0.50
HIF1A Q16665 1/20 0.50
KMT2A Q03164 2/20 0.48
HSD17B10 Q99714 1/20 0.47
ALDH1A1 P00352 2/20 0.47
MEN1 O00255 1/20 0.47
USP2 O75604 1/20 0.47
TP53 P04637 1/20 0.47
POLB P06746 1/20 0.47
GAA P10253 1/20 0.47
CASP1 P29466 1/20 0.47
HTT P42858 1/20 0.47
CASP7 P55210 1/20 0.47
ATM Q13315 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24306566 0.90 L3MBTL1 (0.50) MAPTL3MBTL1PKMCSNK2A1HTR2C
SCHEMBL3794601 0.90 L3MBTL1 (0.53) MAPTL3MBTL1PKMHTR2CHTR2B
Acetic Acid SCHEMBL10997412 0.89 MAPT (0.51) MAPTL3MBTL1PKMHTR2CHTR2B
SCHEMBL26667637 0.86 ALDH1A1 (0.54) MAPTL3MBTL1PKMCSNK2A1HTR2C
SCHEMBL257320 0.86 CSNK2A1 (0.64) MAPTL3MBTL1PKMCSNK2A1HIF1A
SCHEMBL8234481 0.84 KDM4E (0.56) MAPTL3MBTL1PKMCSNK2A1HTR2C
SCHEMBL2525158 0.83 TSHR (0.56) MAPTL3MBTL1HTR2CHTR2BKDM4E
SCHEMBL363534 0.82 MAPT (0.66) MAPTL3MBTL1PKMCSNK2A1HTR2C
SCHEMBL3784669 0.82 MAPT (0.51) MAPTL3MBTL1PKMCSNK2A1HTR2C
SCHEMBL5972769 0.82 MAPT (0.47) MAPTL3MBTL1PKMCSNK2A1HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 MAPT 3312/4885L3MBTL1 3838/4885PKM 3517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.